Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950149-04-000279
Filing Date
2004-02-05
Accepted
2004-02-05 11:59:32
Documents
10

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.4 TO FORM S-1 f93670a4sv1za.htm S-1/A 1273512
3 EXHIBIT 3.1 f93670a4exv3w1.txt EX-3.1 12331
4 EXHIBIT 3.2 f93670a4exv3w2.txt EX-3.2 79030
5 EXHIBIT 5.1 f93670a4exv5w1.txt EX-5.1 1816
6 EXHIBIT 10.18 f93670a4exv10w18.txt EX-10.18 296178
7 EXHIBIT 23.2 f93670a4exv23w2.txt EX-23.2 642
8 EXHIBIT 23.3 f93670a4exv23w3.txt EX-23.3 796
10 GRAPHIC f93670a4f9367000.gif GRAPHIC 4136
11 GRAPHIC f93670a4f9367005.gif GRAPHIC 113866
12 GRAPHIC f93670a4f9367011.gif GRAPHIC 28364
  Complete submission text file 0000950149-04-000279.txt   1813209
Mailing Address 9500 GILMAN DR UNIVERSITY OF CALIFORNIA LA JOLLA CA 92093-0663
Business Address 717 POTTER STREET, SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 943378733 | State of Incorp.: DE
Type: S-1/A | Act: 33 | File No.: 333-109965 | Film No.: 04569141
SIC: 2834 Pharmaceutical Preparations